In the following section, we will categorize GMB-derived substances altered in metabolic diseases into amino acids, fatty acids, other metabolites, and extracellular vesicles (EVs), as these classifications can give us a subsequent hypothesis of how each metabolite regulates AD pathogenesis through specific signaling mechanisms associated with mitochondria and ELN function (Fig. 2). Here, ELN is linked to Alzheimer disease.